Stacey Bilinski
Hoofd Techniek/Wetenschap/O&O bij IN8BIO, INC.
Profiel
Stacey Bilinski is currently the Vice President-Clinical Operations at IN8bio, Inc. Prior to this, Stacey worked as the Global Senior Director-Operations at Taiho Oncology, Inc. from 2015 to 2022.
Stacey also held the position of Executive Director-Clinical Operations at Traws Pharma, Inc. Stacey completed their undergraduate degree at Rutgers State University of New Jersey.
Actieve functies van Stacey Bilinski
| Bedrijven | Functie | Begin |
|---|---|---|
| IN8BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 13-04-2022 |
Eerdere bekende functies van Stacey Bilinski
| Bedrijven | Functie | Einde |
|---|---|---|
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Operationeel Directeur | 01-03-2022 |
| TRAWS PHARMA, INC. | Corporate Officer/Principal | - |
Opleiding van Stacey Bilinski
| Rutgers State University of New Jersey | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IN8BIO, INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |